|
No records
|
|
555 |
Susanto A.D., Winardi W., Hidayat M., Wirawan A. |
57190425587;57211654146;56435992700;57221412258; |
The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia |
2021 |
Reviews on Environmental Health |
36 |
1 |
|
95 |
99 |
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094149752&doi=10.1515%2freveh-2020-0062&partnerID=40&md5=a7a8a53669f01afb3fc072e87f174a11 |
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia |
Susanto, A.D., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Winardi, W., Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Hidayat, M., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Wirawan, A., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia |
Indoor air pollution marked with decreased air quality below the set standard. The quality of indoor air is determined by ambient air quality as well as by a harmful substance resulting from the household activity. Indoor air pollution may cause several problems such as sick building syndrome, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and is responsible for nearly two million death in developing countries. One of the interesting research topics to overcome the indoor air pollution problem is the application of indoor plants. Although there are no established criteria to specify the best indoor plant, several studies have revealed the capability of a particular indoor plant to remove the harmful substances. This paper summarizes important information about indoor air pollution and provides the evidence-based insight of indoor plant usefulness as an alternative way for indoor air remediation. © 2021 De Gruyter. All rights reserved. |
Air pollution; Air quality; Indoor air pollution |
ecosystem restoration; human; Indonesia; indoor air pollution; plant; prevention and control; procedures; Air Pollution, Indoor; Environmental Restoration and Remediation; Humans; Indonesia; Plants |
De Gruyter Open Ltd |
00487554 |
|
32920542 |
Review |
Q2 |
644 |
7826 |
|
|
|
560 |
Purbadi S., Saspriyana K.Y. |
6505677307;57215693910; |
Primary debulking surgery of advanced epithelial ovarian cancer in developing countries: Challenges and expectations |
2021 |
European Journal of Gynaecological Oncology |
42 |
1 |
|
26 |
29 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101075370&doi=10.31083%2fj.ejgo.2021.01.2230&partnerID=40&md5=7e3562ded7816ae8267f39ec3c207282 |
Gynaecology Oncology Division, Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, 10430, Indonesia; Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, 80113, Indonesia |
Purbadi, S., Gynaecology Oncology Division, Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, 10430, Indonesia; Saspriyana, K.Y., Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia, Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, 80113, Indonesia |
Ovarian cancer often presents itself in advanced stages and can be accompanied by various comorbidities. Treatment options are primary debulking surgery (PDS) followed by adjuvant chemotherapy, or alternatively, neoadjuvant chemotherapy followed by interval debulking surgery (IDS). The option taken is based on several considerations. If the patient can be treated with PDS, the absence of macroscopic residual disease becomes an independent prognostic factor. However, achieving this outcome is a challenge for the gynaecologic oncologist since advanced stage ovarian cancer generally metastasizes into the peritoneum and the upper abdominal organs. Optimal outcomes are that surgery will be safe for the patient, no macroscopic residual disease is achieved, minimal postoperative complications are encountered, and a good survival rate is obtained. Developed countries, especially Europe, have well-recognized standards of care which are followed by developing countries; however, challenges with insurance coverage and inter-departmental cooperation are recognized hurdles in developing countries. Competency improvement along with good inter-departmental communication and collaboration are keys to optimal outcomes for PDS. © 2021 The Authors. Published by IMR Press. |
Competency; Interdepartmental approach; Ovarian cancer; Primary debulking surgery; Residual disease |
abdominal viscera; cancer prognosis; cancer staging; cytoreductive surgery; developing country; Europe; European; female; health insurance; human; intersectoral collaboration; learning; medical society; minimal residual disease; outcome assessment; ovary carcinoma; peritoneum metastasis; postoperative complication; public-private partnership; Review; survival rate |
IMR Press Limited |
03922936 |
|
|
Review |
Q4 |
150 |
23157 |
|
|
|
561 |
Nadzir M.M., Nurhayati R.W., Idris F.N., Nguyen M.H. |
8668648100;55748436600;57194239683;55319059400; |
Biomedical applications of bacterial exopolysaccharides: A review |
2021 |
Polymers |
13 |
4 |
530 |
1 |
25 |
|
9 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101211712&doi=10.3390%2fpolym13040530&partnerID=40&md5=0563148d938735dbc6e7b156a85abe90 |
School of Chemical Engineering, Engineering Campus, Universiti Sains Malaysia, Nibong Tebal, 14300, Malaysia; Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Depok, 16424, Indonesia; Stem Cell and Tissue Engineering Research Cluster, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Faculty of Biotechnology, Chemistry and Environmental Engineering, Phenikaa University, Hanoi, 12116, Viet Nam; Bioresource Research Center, Phenikaa University, Hanoi, 12116, Viet Nam |
Nadzir, M.M., School of Chemical Engineering, Engineering Campus, Universiti Sains Malaysia, Nibong Tebal, 14300, Malaysia; Nurhayati, R.W., Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Depok, 16424, Indonesia, Stem Cell and Tissue Engineering Research Cluster, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, Jakarta, 10430, Indonesia; Idris, F.N., School of Chemical Engineering, Engineering Campus, Universiti Sains Malaysia, Nibong Tebal, 14300, Malaysia; Nguyen, M.H., Faculty of Biotechnology, Chemistry and Environmental Engineering, Phenikaa University, Hanoi, 12116, Viet Nam, Bioresource Research Center, Phenikaa University, Hanoi, 12116, Viet Nam |
Bacterial exopolysaccharides (EPSs) are an essential group of compounds secreted by bacteria. These versatile EPSs are utilized individually or in combination with different materials for a broad range of biomedical field functions. The various applications can be explained by the vast number of derivatives with useful properties that can be controlled. This review offers insight on the current research trend of nine commonly used EPSs, their biosynthesis pathways, their characteristics, and the biomedical applications of these relevant bioproducts. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
Alginate; Bacteria; Biomedical; Cellulose; Dextran; Exopolysaccharides; Gellan; Hyaluronic acid; Levan; Xanthan gum |
Biochemistry; Bioproducts; Medical applications; Biomedical applications; Biomedical fields; Biosynthesis pathways; Exopolysaccharides; Research trends; Useful properties; Polysaccharides |
MDPI AG |
20734360 |
|
|
Review |
Q1 |
770 |
6319 |
|
|
|
564 |
Ahlam Syakirah W.N., Shafie W.M., Mansyur M., Nor N.Md. |
57223025872;57223022488;37085506800;57209597416; |
A Systematic Review on Precision Nutrition for Prevention and Management of Obesity during COVID-19 |
2021 |
Pakistan Journal of Medical and Health Sciences |
15 |
2 |
|
223 |
230 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104525366&partnerID=40&md5=abe25d87c69c1fb5f8ba0283e4701cc2 |
Centre of Nutrition and Dietetics Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Malaysia; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia; Maternal, Infant & Young Child Nutrition (MiChild) Research Group, Faculty of Health Sciences, Universiti Teknologi MARA, Malaysia |
Ahlam Syakirah, W.N.; Shafie, W.M., Centre of Nutrition and Dietetics Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Malaysia; Mansyur, M., Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia; Nor, N.Md., Centre of Nutrition and Dietetics Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Malaysia, Maternal, Infant & Young Child Nutrition (MiChild) Research Group, Faculty of Health Sciences, Universiti Teknologi MARA, Malaysia |
The COVID-19 pandemic is now catching the country by surprise. The disease has had a huge influence worldwide, and the nation has been put in lockdown by this health crisis. The psychological health, physical health and economic condition of individuals are adversely impacted by quarantine and lockdown. As mobility is reduced, there will be a dramatic shift in the population's lifestyle, where the people's physical activity level will decrease. Low levels of physical exercise can lead to a large number of obesity cases. Therefore, steps for obesity prevention and management need to be taken. One approach is to administer nutrition with accuracy through precision nutrition. Therefore, this research aims to review articles on precision nutrition for the treatment and control of obesity towards a restricted movement order during the COVID-19 health crisis. The literature search was conducted from May 2020 until January 2021 using Scopus and Science Direct as the main databases. The articles included follow the inclusion criteria published in English language, including nutrition intervention for prevention and management of obesity, focus on health crisis, and no restriction of time and study design. Various studies show that precision nutrition has a potential benefit in preventing or controlling obesity prevalence due to restricted movement order or quarantine upon health crisis. © 2021 Lahore Medical And Dental College. All rights reserved. |
COVID-19; Lockdown; Obesity; Precision nutrition; Quarantine |
|
Lahore Medical And Dental College |
19967195 |
|
|
Review |
Q4 |
114 |
27922 |
|
|
|
574 |
Khaedir Y., Kartika R. |
57210448725;57216548032; |
Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19 |
2021 |
Journal of Interferon and Cytokine Research |
41 |
2 |
|
37 |
43 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101400819&doi=10.1089%2fjir.2020.0135&partnerID=40&md5=98ca5a1b9e49b8a60fe141024cc36031 |
Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Immunology, Master's Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Division of Metabolic, Endocrinology and Diabetes, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia |
Khaedir, Y., Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia, Immunology, Master's Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Kartika, R., Division of Metabolic, Endocrinology and Diabetes, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia |
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been a major threat to global public health. In Indonesia, the cases have rapidly increased, and the case fatality rate remains high. With COVID-19, most of the deaths have been caused by acute respiratory distress syndrome and dysregulation of the immune response. A lung biopsy from a patient with COVID-19 showed inflammatory cellular infiltration with diffuse alveolar damage. Massive pulmonary destruction has also been reported as a result of highly increased levels of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, interferon-γ(IFN-γ), induced protein 10 (IP-10), and monocyte chemoattractant protein-1 (MCP-1). IL-6 is an inflammatory cytokine produced by various cell types, including immune cells and nonleukocytes, such as endothelial cells, fibroblasts, epithelial cells, type II pneumocytes, and certain tumor cells. Several studies have shown that IL-6 contributes to the severity and mortality of COVID-19. In this review, we would like to explore the immune response in COVID-19 and the role of IL-6 in the immunopathogenesis of COVID-19. © Copyright 2021, Mary Ann Liebert, Inc., publishers 2021. |
coronavirus disease 2019; immune response; interleukin-6 |
interleukin 6; tocilizumab; IL6 protein, human; interleukin 6; interleukin 6 receptor; JAK1 protein, human; JAK2 protein, human; Janus kinase 1; Janus kinase 2; Janus kinase inhibitor; monoclonal antibody; pyrazole derivative; ruxolitinib; sarilumab; tocilizumab; cell infiltration; clinical outcome; coronavirus disease 2019; cytokine storm; human; immune response; immunopathogenesis; lung alveolus cell; priority journal; prospective study; Review; Severe acute respiratory syndrome coronavirus 2; signal transduction; cytokine release syndrome; drug effect; immunology; Indonesia; pathology; respiratory distress syndrome; Antibodies, Monoclonal, Humanized; COVID-19; Cytokine Release Syndrome; Humans; Indonesia; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Janus Kinase Inhibitors; Pyrazoles; |
Mary Ann Liebert Inc. |
10799907 |
|
33621130 |
Review |
Q1 |
1031 |
4200 |
|
|
|
575 |
Fuady A., Houweling T.A.J., Richardus J.H. |
37085331400;10639726000;7003977198; |
Perspective piece COVID-19 and tuberculosis-related catastrophic costs |
2021 |
American Journal of Tropical Medicine and Hygiene |
104 |
2 |
|
436 |
440 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101400221&doi=10.4269%2fajtmh.20-1125&partnerID=40&md5=a3c370677fb6cad8407b4d92b3768798 |
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Fuady, A., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Houweling, T.A.J., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Richardus, J.H., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands |
The COVID-19 pandemic has created an unprecedented health crisis and a substantial socioeconomic impact. It also affects tuberculosis (TB) control severely worldwide. Interruptions of many TB control programs because of the COVID-19 pandemic could result in significant setbacks. One of the targets that can be affected is the WHO's End TB Strategy goal to eliminate catastrophic costs of TB-affected households by 2030. Disruptions to TB programs and healthcare services due to COVID-19 could potentially prolong diagnostic delays and worsen TB treatment adherence and outcomes. The economic recession caused by the pandemic could significantly impact household financial capacity because of the reduction of income and the rise in unemployment rates. All of these factors increase the risk of TB incidence and the gravity of economic impact on TB-affected households, and hamper efforts to eliminate catastrophic costs and control TB. Therefore, efforts to eliminate the incidence of TB-affected households facing catastrophic costs will be very challenging. Because financial constraint plays a significant role in TB control, the improvement of health and social protection systems is critical. Even before the pandemic, many TB-high-burden countries (HBCs) lacked robust health and social protection systems. These challenges highlight the substantial need for a more robust engagement of patients and civil society organizations and international support in addressing the consequences of COVID-19 on the control of TB. © 2021 by The American Society of Tropical Medicine and Hygiene. |
|
tuberculostatic agent; clinical outcome; coronavirus disease 2019; delayed diagnosis; disaster; disease burden; disease control; economic recession; financial management; health care cost; health program; health service; household; human; incidence; income; infection control; infection risk; organization; pandemic; patient compliance; Review; social aspect; social protection system; socioeconomics; tuberculosis; unemployment; World Health Organization; economics; family size; health care cost; tuberculosis; COVID-19; Family Characteristics; Health Care Costs; Humans; Incidence; Income; SARS-CoV-2; Tuberculosis |
American Society of Tropical Medicine and Hygiene |
00029637 |
|
33269683 |
Review |
Q1 |
1015 |
4298 |
|
|
|
581 |
Nugroho S.W., Perkasa S.A.H., Gunawan K., Manuhutu Y.N., Rahman M.A., Rizky A. |
57460519700;57204105609;57195935319;57221807460;57221807438;57221806899; |
Predicting outcome of hemifacial spasm after microvascular decompression with intraoperative monitoring: A systematic review |
2021 |
Heliyon |
7 |
2 |
e06115 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100277933&doi=10.1016%2fj.heliyon.2021.e06115&partnerID=40&md5=b7d2f2e7bfd453c5d93d9b6eb24a6a19 |
Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia |
Nugroho, S.W., Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia; Perkasa, S.A.H., Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia; Gunawan, K., Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia; Manuhutu, Y.N., Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia; Rahman, M.A., Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia; Rizky, A., Neurofunctional Division, Department of Neurosurgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Indonesia |
Hemifacial spasm, Microvascular decompression, Intraoperative monitoring, Lateral spread response, Abnormal muscle response. © 2021 The AuthorsBackground: Microvascular decompression has been established as a primary treatment for hemifacial spasm. Intraoperative monitoring is used during the surgery to guide neurosurgeons to determine whether the decompression of facial nerve from the vessel is sufficient. We performed a systematic review to assess the role of lateral spread response (LSR) monitoring in predicting hemifacial spasm outcomes after microvascular decompression. Method: A systematic search of PubMed, ScienceDirect, Cochrane, and Google Scholar was conducted. We included studies that performed microvascular decompression surgery with intraoperative monitoring analyzing the correlation between lateral spread response and spasm relief. A critical appraisal was conducted for selected studies. Result: Twenty-two studies comprising 6404 cases of hemifacial spasm, which underwent microvascular decompression surgery with intraoperative monitoring, were included. Of 15 articles that assessed symptoms shortly after surgery, 12 studies showed a significant correlation between lateral spread response resolution and disappearance of spasm. Four of six studies that evaluated the outcome at 3-month follow-up showed significant relationship between LSR and outcome, so did five of six articles that assessed spasm relief at 6-month follow-up. As much as 62.5% of studies (10 of 16) showed the result at long-term follow-up (≥1-year) was not significant. Conclusion: Intraoperative monitoring during microvascular decompression surgery can be a useful tool to predict hemifacial spasm resolution. Though long-term outcomes of patients with LSR relief and persistence are similar, resolution of symptoms shortly after surgery will provide comfort to patients thereby improving their quality of life. © 2021 The Authors |
Abnormal muscle response; Hemifacial spasm; Intraoperative monitoring; Lateral spread response; Microvascular decompression |
|
Elsevier Ltd |
24058440 |
|
|
Review |
Q1 |
455 |
10919 |
|
|
|
592 |
Pribadi R.R., Simadibrata M. |
57194732282;23499598400; |
Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury? |
2021 |
JGH Open |
5 |
2 |
|
190 |
192 |
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098140408&doi=10.1002%2fjgh3.12436&partnerID=40&md5=14da866c743f8e6c2bdfff73d45cc7a5 |
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Pribadi, R.R., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Simadibrata, M., Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Coronavirus disease 2019 (COVID-19) is a novel disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it mainly affects the respiratory system, the pancreas could also become the virus' target. The issue regarding pancreatic involvement in COVID-19 has been raised by several researchers. They found increased serum amylase and/or lipase in COVID-19 patients, which suggested pancreatic injury. We aimed to critically review the evidence to provide insights and to answer the very question of the possibility of pancreatic injury. Current evidence shows that increased amylase and/or lipase is not necessarily a pancreatic injury in COVID-19 patients. Those increased enzymes might also be found in other clinical conditions. © 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. |
amylases; COVID-19; lipase; pancreas |
|
John Wiley and Sons Inc |
23979070 |
|
|
Review |
Q3 |
546 |
9258 |
|
|
|
593 |
Tedjasukmana D., Triangto K., Radi B. |
57208885305;56153395600;6603494019; |
Aerobic exercise prescription in heart failure patients with cardiac resynchronization therapy |
2021 |
Journal of Arrhythmia |
37 |
1 |
|
165 |
172 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097280088&doi=10.1002%2fjoa3.12475&partnerID=40&md5=9c74c529949e818075ba5b96c9268b86 |
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Tedjasukmana, D., Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Triangto, K., Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Radi, B., Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Exercise for heart failure patients had been shown to be beneficial in improving functional status, and was reviewed to be safe. In cases of advanced heart failure, Cardiac Resynchronization Therapy (CRT) is a promising medical option before being a heart transplant candidate. CRT itself is a biventricular pacing device, which could detect electrical aberrance in the failing heart and provide a suitable response. Studies have shown that exercise has clear benefits toward improving an overall exercise capacity of the patients. Despite its impacts, these randomized clinical trials have varying exercise regime, and until now there has not been a standardized exercise prescription for this group of patients. The nature of CRT as a pacemaker, sometimes with defibrillator, being attached to a heart failure patient, each has its own potential exercise hazards. Therefore, providing detailed exercise prescription in adjusting to the medical condition is very essential in the field of physical medicine and rehabilitation. Being classified as a high-risk patient group, exercise challenges for the complex heart failure with CRT patients will then be discussed in this literature review, with a general aim to provide a safe, effective, and targeted exercise regime. © 2020 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society. |
aerobic exercise prescription; cardiac resynchronization therapy; functional capacity; heart failure; rehabilitation |
aerobic exercise; atrial fibrillation; breathing exercise; cardiac resynchronization therapy; cardiopulmonary exercise test; cardiovascular magnetic resonance; congestive heart failure; coronary sinus; dyspnea; echocardiography; electrocardiography; endurance training; estimated glomerular filtration rate; exercise; exercise intensity; functional status; glycemic control; heart failure; heart function; heart left ventricle ejection fraction; heart output; heart rate; heart stroke volume; heart ventricle arrhythmia; heart ventricle fibrillation; heart ventricle tachycardia; high intensity interval training; human; hypertrophic cardiomyopathy; muscle atrophy; muscle strength; myocarditis; noninvasive ventilation; oxygen consumption; oxygen saturation; pH; physical activity; postoperative com |
Wiley-Blackwell |
18804276 |
|
|
Review |
Q3 |
463 |
10757 |
|
|
|
601 |
Siswanto J.E., Bos A.F., Dijk P.H., Rohsiswatmo R., Irawan G., Sulistijono E., Sianturi P., Wisnumurti D.A., Wilar R., Sauer P.J.J. |
57205060577;36839156800;6701798049;55533574600;57221815645;57218101844;57192896614;57200574807;57201130415;57221818237; |
Multicentre survey of retinopathy of prematurity in Indonesia |
2021 |
BMJ Paediatrics Open |
5 |
1 |
e000761 |
|
|
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100318807&doi=10.1136%2fbmjpo-2020-000761&partnerID=40&md5=0c40a01ee7a27d4289754e988161b732 |
Neonatology, Universitair Medisch Centrum Groningen, Groningen, Netherlands; Neonatology, Harapan Kita National Centre for Women and Children's Health, Jakarta, Indonesia; Neonatology, University Medical Center Groningen Intensive Care Medicine, Groningen, Netherlands; Pediatric, University of Indonesia Faculty of Medicine, Jakarta, Indonesia; Pediatric, Dr Kariadi General Hospital Medical Center, Semarang, Central Java, Indonesia; Pediatric, Dr Saiful Anwar General Hospital, Malang, Jawa Timur, Indonesia; Pediatric, University of Sumatera Utara Faculty of Medicine, Medan, North Sumatera, Indonesia; Pediatric, University of Riau Faculty of Medicine, Pekanbaru, Riau, Indonesia; Pediatric, Sam Ratulangi University Faculty of Medicine, Manado, North Sulawesi, Indonesia |
Siswanto, J.E., Neonatology, Universitair Medisch Centrum Groningen, Groningen, Netherlands, Neonatology, Harapan Kita National Centre for Women and Children's Health, Jakarta, Indonesia; Bos, A.F., Neonatology, University Medical Center Groningen Intensive Care Medicine, Groningen, Netherlands; Dijk, P.H., Neonatology, Universitair Medisch Centrum Groningen, Groningen, Netherlands; Rohsiswatmo, R., Pediatric, University of Indonesia Faculty of Medicine, Jakarta, Indonesia; Irawan, G., Pediatric, Dr Kariadi General Hospital Medical Center, Semarang, Central Java, Indonesia; Sulistijono, E., Pediatric, Dr Saiful Anwar General Hospital, Malang, Jawa Timur, Indonesia; Sianturi, P., Pediatric, University of Sumatera Utara Faculty of Medicine, Medan, North Sumatera, Indonesia; Wisnumurti, D.A., Pediatric, University of Riau Faculty of Medicine, Pekanbaru, Riau, Indonesia; Wilar, R., Pediatric, Sam Ratulangi University Faculty of Medicine, Manado, North Sulawesi, Indonesia; Sauer, P.J.J., Neonatology, Universitair Medisch Centrum Groningen, Groningen, Netherlands |
Background: The incidence of retinopathy of prematurity (ROP) is higher in Indonesia than in high-income countries. In order to reduce the incidence of the disease, a protocol on preventing, screening and treating ROP was published in Indonesia in 2010. To assist the practical implementation of the protocol, meetings were held in all Indonesia regions, calling attention to the high incidence of ROP and the methods to reduce it. In addition, national health insurance was introduced in 2014, making ROP screening and treatment accessible to more infants. Objective To evaluate whether the introduction of both the guideline drawing attention to the high incidence of ROP and national health insurance may have influenced the incidence of the disease in Indonesia. Setting Data were collected from 34 hospitals with different levels of care: national referral centres, university-based hospitals, and public and private hospitals. Methods: A survey was administered with questions on admission numbers, mortality rates, ROP incidence, and its stages for 2016-2017 in relation to gestational age and birth weight. Results: We identified 12 115 eligible infants with a gestational age of less than 34 weeks. Mortality was 24% and any stage ROP 6.7%. The mortality in infants aged less than 28 weeks was 67%, the incidence of all-stage ROP 18% and severe ROP 4%. In the group aged 28-32 weeks, the mortality was 24%, all-stage ROP 7% and severe ROP 4%-5%. Both mortality and the incidence of ROP were highest in university-based hospitals. Conclusions: In the 2016-2017 period, the infant mortality rate before 32 weeks of age was higher in Indonesia than in high-income countries, but the incidence of ROP was comparable. This incidence is likely an underestimation due to the high mortality rate. The ROP incidence in 2016-2017 is lower than in surveys conducted before 2015. This decline is likely due to a higher practitioner awareness about ROP and national health insurance implementation in Indonesia. © Author(s) (or their employer(s)) 2021. |
epidemiology; health services research; mortality; neonatology; ophthalmology |
birth weight; controlled study; data collection method; disease severity; female; gestational age; health services research; health survey; high income country; human; incidence; Indonesia; infant; infant mortality; major clinical study; male; mortality rate; multicenter study; national health insurance; patient referral; physician; practice guideline; prematurity; priority journal; private hospital; public hospital; retrolental fibroplasia; Review; teaching hospital; university hospital |
BMJ Publishing Group |
23999772 |
|
|
Review |
Q1 |
821 |
5832 |
|
|
